Lophos Holdings Inc., owner of a biosciences business licensed for the cultivation, research and sale of Peyote and other controlled substances, has received approval for the listing of its common shares on the Canadian Securities Exchange (CSE).
The company expects to start trading on the CSE around September 6, 2023, under the ticker symbol "MESC".
The company, whose main business is the indoor cultivation, research and sale of Lophophora williamsii -aka Peyote cactus, holds a Canadian Controlled Substances Dealer’s License enabling it to sell the psychedelic through an exemption to the country’s Controlled Drugs and Substances Act. It can also sell on international markets including the Czech Republic, Netherlands, Peru, Portugal, Slovenia, Sweden, Thailand, Ukraine, the U.K., Germany, and the U.S. for indigenous and religious use.
“We are thrilled to introduce our mission to the public markets through a direct listing on the CSE," said CEO Claire Stawnyczy. “We are looking forward to the future of the psychedelic industry and are excited for the tremendous positive impact Lophos Pharmaceuticals Corp. will have on the availability of legal psychedelics in Canada.”
See Also: Canada Vs. US: Surveys Reveal How People Use Psychedelics, Relationships With Healthcare Providers
Stawnyczy views the listing as an important step toward realizing Lophos’ dual mission of advancing novel mental health therapies while “establishing a sustainable and ethical source for a sacred traditional medicine."
Interested in other natural medicines markets? Our biannual Cannabis Capital Conference is coming up! Whether to close your deals or just get acquainted with the sector’s best, come join us this Sept. 27-28 in Chicago for our 17th edition! Tickets HERE.
Photo: Benzinga edit with photo by Zita and canadastock on Shutterstock.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!